Skip to main content
Premium Trial:

Request an Annual Quote

InVivoScribe Gets European OK for Leukemia Mutation Assay

NEW YORK (GenomeWeb News) – InVivoScribe Technologies has received the CE IVD Mark for its LeukoStrat FLT3 Mutation Assay, the San Diego-based firm said today.

The PCR-based assay detects internal tandem duplications and point mutations in the FLT3 gene from whole blood or bone marrow in patients with acute myelogenous leukemia. According to privately held InVivoScribe, the mutation status of the FLT3 receptor gene is the most important prognostic indicator of disease outcome in cytogenically normal AML.

The firm said that the World Health Organization has recommended evaluation of FLT3 mutation status in CN-AML to assist in the clinical management of patients with AML.

"The FLT3 assay is the first of what we expect will be a number of CE marked LeukoStrat assays we will introduce to test key prognostic markers in hematologic malignancies," InVivoScribe CSO and CEO Jeffrey Miller said in a statement.

Filed under

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.